Cytek Biosciences Balance Sheet
NASDAQ: CTKBIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cytek Biosciences financial position
At the end of fiscal 2025, Cytek Biosciences reported total assets of $461.5 million, down 7.6% from a year earlier against total liabilities of $119.8 million. Shareholders' equity stood at $341.7 million, or 74.0% of assets. The company held $90.9 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 5.04, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Cytek Biosciences balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 90.85M | 98.72M | 167.30M | 296.60M | 364.62M | 165.23M |
| Receivables | 62.51M | 60.59M | 55.93M | 48.86M | 29.76M | 16.99M |
| Inventory | 48.43M | 43.89M | 60.88M | 48.15M | 32.17M | 23.02M |
| Total Current Assets | 392.00M | 396.45M | 392.06M | 454.02M | 431.73M | 208.62M |
| Property, Plant & Equipment | 18.01M | 17.96M | 18.41M | 13.68M | 5.85M | 2.14M |
| Goodwill | 16.70M | 16.66M | 16.18M | 10.14M | 10.14M | 476.00K |
| Intangible Assets | 16.82M | 20.13M | 23.08M | 4.33M | 4.74M | 274.00K |
| Total Assets | 461.54M | 499.50M | 494.46M | 519.48M | 463.31M | 219.98M |
| Accounts Payable | 6.41M | 5.53M | 3.03M | 4.80M | 3.03M | 2.94M |
| Total Current Liabilities | 77.80M | 67.66M | 56.23M | 49.04M | 33.18M | 26.54M |
| Total Liabilities | 119.80M | 103.76M | 101.39M | 93.93M | 57.92M | 41.69M |
| Shareholders' Equity | 341.74M | 395.74M | 393.06M | 425.55M | 405.38M | -16.03M |
| Retained Earnings | -101.74M | -35.20M | -29.18M | -17.03M | -19.61M | -22.61M |
| Net Cash (Debt) | 90.85M | 98.72M | 167.30M | 296.60M | 364.62M | 165.23M |
| Shares Outstanding | 128.55M | 129.21M | 130.71M | 135.37M | 133.75M | 31.24M |
This table shows 6 annual periods of Cytek Biosciences's balance sheet, from FY 2025 back to FY 2020, across 15 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow CTKB's reporting calendar. What is a balance sheet?